EC Paediatrics

Case Report Volume 12 Issue 1 - 2023

Are Amniocentesis Results 100% Reliable?

Jorge Sales Marques*

Hospital Cuf Trindade, Porto, Portugal

*Corresponding Author: Jorge Sales Marques, Hospital Cuf Trindade, Porto, Portugal.
Received: November 04, 2022; Published: December 16, 2022



Beckwith-Wiedemann syndrome (BWS) is characterized by neonatal hypoglycemia, macrosomia, macroglossia, omphalocele, visceromegaly and ear creases.

We presented a case of a female newborn with phenotype of BWS.

The prenatal diagnosis showed normal karyotype. The postnatal high resolution band karyotype confirmed the diagnosis with change in the chromosome 11. The father and paternal grandfather showed equilibrated translocation of terminal part of short arm of chromosome 3 and 11.

The reason why the karyotype was normal is because during the amniocentesis, the high resolution band is more difficult to obtain in culture and normally this technique is not use. To avoid repeat this situation in the next pregnancy, we need to do FISH of chromosome 11 to exclude BWS. The risk of recurrence is 50%.

Keywords: Beckwith-Wiedemann Syndrome; Amniocentesis; FISH

  1. Algar E., et al. “Analysis of CDKN1C in Beckwith Wiedemann syndrome”. Human Mutation 15 (2000): 497-508.
  2. Alsultan A., et al. “Simultaneous occurrence of right adrenocortical tumor and left adrenal neuroblastoma in an infant with Beckwith-Wiedemann syndrome”. Pediatric Blood and Cancer 51 (2008): 695-698.
  3. Arboleda VA., et al. “Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome”. Nature Genetics 44 (2012): 788-792.
  4. Barlow DP. “Imprinting: a gamete's point of view”. Trends in Genetics 10 (1994): 194-199.
  5. Baskin B., et al. “High frequency of copy number variations (CNVs) in the chromosome 11p15 region in patients with Beckwith-Wiedemann syndrome”. Human Genetics 133 (2014): 321-330.
  6. Baujat G., et al. “Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome”. American Journal of Human Genetics 74 (2004): 715-720.
  7. Beckwith JB. “Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations”. American Journal of Medical Genetics 79 (1998): 268-273.
  8. Bliek J., et al. “Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS”. Human Molecular Genetics 10 (2001): 467-476.
  9. Bliek J., et al. “Hypomethylation at multiple maternally methylated imprinted regions including PLAGL1 and GNAS loci in Beckwith-Wiedemann syndrome”. European Journal of Human Genetics 17 (2009): 611-619.
  10. Borer JG., et al. “Renal findings on radiological followup of patients with Beckwith-Wiedemann syndrome”. The Journal of Urology 161 (1999): 235-239.
  11. Brioude F., et al. “Mutations of the Imprinted CDKN1C Gene as a Cause of the Overgrowth Beckwith-Wiedemann Syndrome: Clinical Spectrum and Functional Characterization”. Human Mutation 36 (2015): 894-902.
  12. Brioude F., et al. “CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome”. Journal of Medical Genetics 50 (2013): 823-830.

Jorge Sales Marques. Are Amniocentesis Results 100% Reliable?. EC Paediatrics 12.1 (2023):20-23 .